Success Stories: A Principal Scientist in the Field of Oncology Secures NIW and EB1A Approvals Miraculously on the Same Day with our Continuous Support


Client’s Testimonial:

“Thank you so much for your help!”

On October 1st, we received another EB2-NIW (National Interest Waiver) and EB-1A (Alien of Extraordinary Ability) approval for a Principal Scientist in the Field of Oncology (Approval Notice).

General Field: Oncology

Position at the Time of Case Filing: Principal Scientist

Country of Origin: Hong Kong

State of Residence at the Time of Filing: Massachusetts

Approval Notice Date: October 1st, 2021 (NIW & EB-1A)

Processing Time: 9 months, 22 days (NIW) and 11 months, 20 days (EB-1A)

Case Summary:

Initially, our client, a principal scientist with a Ph.D. in molecular oncology from Hong Kong, approached North America Immigration Law Group to help her in filing an I-140 petition under the national interest waiver visa category and within two months she decided to retain our services for another I-140 petition documentation under the alien of extraordinary ability visa category. Despite two different petition categories, we have first-hand knowledge of how to exactly file these two petitions consecutively to acquire the desired result for our clients.

Therefore, both EB-2 NIW (National Interest Waiver) and EB1-A (Alien of Extraordinary Ability) petition approvals were granted on the same day to our client. When we commenced with the attorney-client relationship agreement, the first and foremost task for our team was to evaluate her provided credentials to determine her NIW and EB1A victory respectively. We were certain that we would be able to lead her to obtain the approvals successfully.

After analyzing her background, paperwork, and the associated evidence, we were pretty much confident that they were inevitable to persuade USCIS, thus, we incorporated the following in her respective petition packets:

  • The 13 peer-reviewed journal articles she published in no fewer than 6 highly ranked peer-reviewed journals in the field of oncology.
  • A great record of 515 citations was acquired from her published work, proving that many other experts have utilized her findings and strategies with favorable results.
  • Cited by researchers in at least 44 countries.
  • She has also been invited to review and evaluate the work of her peers no fewer than 29 times, serving as major evidence of her superiority in the field.

Moreover, our client’s research is to continue using molecular biology, cancer biology, cancer immunology, cancer target discovery, and drug discovery techniques to identify mechanisms of cancer progression for the development of new drug targets and treatment strategies to improve patient survival. We deduced that her research seemed of great importance because it promotes the development of newer and more effective treatments for one of the largest causes of death around the world, cancer.

In addition, considering her other results provide improved, tailored treatment strategies for lung cancer patients, demonstrating the crucial nature of her studies for improving survival outcomes of lung cancer patients, corroborated further by four recommendation letters obtained from her fellow experts in the field. One of the letters had the below-mentioned statement.

“The importance of identifying new approaches to regulate lung cancer is crucial to curbing the impact of the disease. Lung cancer is the second most common cancer worldwide and has been among the most common cancers overall for several decades. [Client’s] research advances the development of new therapeutic drug targets for patients with lung cancer. Her work has revealed the impact of integrating molecular profiling data to obtain biological insights into formerly uncharacterized lung cancer prognostic biomarkers… Therefore, the importance of her research for advancing novel therapeutics to overcome one of the most common causes of death worldwide must be highlighted.”

Once again, we are delighted that our team was very well successful in persuading USCIS of our client’s research which is relevant to identifying new druggable targets to treat cancer patients. Thus, she achieved both the approvals on the same day, and we would generously like to thank her for trusting our law firm for the I-140 petitions and wish her well in her future endeavors.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 16,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 3,500 in 2019.

If you are interested in filing the green card, please send your CV to for our free evaluation. Our attorneys will email you back with the evaluation result within 24 hours.

Approval Notices:

Success Stories:


Free evaluation email:

Tel: 888.666.0969 (Toll Free)

To see more clients’ testimonials and approvals, please refer to:

Client's Testimonials

Approval Notices

To Learn More About Your Options CLICK HERE

Copyright © North America Immigration Law, All Rights Reserved.